Regional Anesthesia EMG Study
- Disease/Condition
- Surgery
- Drug/Device/Intervention
- BlockSynop surface electromyography device
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Nationwide Children's Hospital
- Location
- Columbus, United States of America
- Phase
- N/A
- Start date
- Aug 09, 2023
- End date
- Dec 01, 2024
- Enrollment
- 124 participants
Determine onset of spinal anesthesia and caudal + general anesthesia using surface EMG as measured by power of signal amplitude.,Determine duration of spinal anesthesia and caudal + general anesthesia using surface EMG as measured by power of signal amplitude. .,Determine density of spinal anesthesia and caudal + general anesthesia using surface EMG as measured by power of signal amplitude.,Determine dermatomal level of spinal anesthesia and caudal + general anesthesia using surface EMG as measured by power of signal amplitude.
This study aims to investigate how non-invasive, non-significant risk EMG monitoring can be
 used intraoperatively to objectively characterize neuraxial anesthesia (i.e. spinal and
 caudal blockade) in pediatric patients undergoing surgery. The investigators will also
 attempt to measure the effect of adjunctive intrathecal clonidine on spinal and caudal
 blockade using EMG. This study also aims to quantify the impact of sevoflurane on basal
 muscle tone based on EMG changes. This study aims to generate pilot data on this subject to
 help design future studies.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06287151
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06287151 through Pure Global AI's free database. This phase not specified trial is sponsored by Nationwide Children's Hospital and is currently Recruiting. The study focuses on Surgery. Target enrollment is 124 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.